Development of primary central nervous system lymphoma in a systemic lupus erythematosus patient after treatment with mycophenolate mofetil and review of the literature-Reference-Cited by-同舟云学术

Development of primary central nervous system lymphoma in a systemic lupus erythematosus patient after treatment with mycophenolate mofetil and review of the literature

Published:2017-02-02 Issue:11 Volume:26 Page:1224-1227
ISSN:0961-2033
Container-title:Lupus
language:en
Short-container-title:Lupus

Author:

Balci M A¹,Pamuk G E²,Unlu E³,Usta U⁴,Pamuk O N¹

Affiliation:

1. Department of Rheumatology, Trakya University Medical Faculty, Edirne, Turkey

2. Department of Hematology, Trakya University Medical Faculty, Edirne, Turkey

3. Department of Radiology, Trakya University Medical Faculty, Edirne, Turkey

4. Department of Pathology, Trakya University Medical Faculty, Edirne, Turkey

Abstract

Primary central nervous system lymphoma (PCNSL) is a rare form of extranodal non-Hodgkin lymphoma and four cases of PCNSL have previously been described in association with mycophenolate mofetil. We report the fifth case of PCNSL in a patient with lupus nephropathy while on mycophenolate mofetil treatment.

Publisher

SAGE Publications

Subject

Rheumatology

Link

http://journals.sagepub.com/doi/pdf/10.1177/0961203317691370

Reference7 articles.

1. Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium

2. Cancer risk in systemic lupus: An updated international multi-centre cohort study

3. A closer look at non-Hodgkin's lymphoma cases in a national Swedish systemic lupus erythematosus cohort: a nested case-control study

4. Central nervous system lymphoma associated with mycophenolate mofetil in lupus nephritis

5. Primary lymphoma of CNS, mycophenolate mofetil and lupus

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A case report of lymphoproliferative disease in brain following therapies with mycophenolate Mofetil and Fingolimod and literature review;Journal of Neuroimmunology;2024-09

2. Cancer and multiple sclerosis: 2023 recommendations from the French Multiple Sclerosis Society;Multiple Sclerosis Journal;2024-02-15

3. A Case Report of Brain Lymphoproliferative Disease After Mycophenolate Mofetil and Fingolimod Therapy;2024

4. Different facets of intracranial central nervous system lymphoma and its imaging mimics;Journal of Clinical Imaging Science;2022-02-04

5. Iatrogenic immunodeficiency‐associated lymphoproliferative disorder secondary to mycophenolate mofetil treatment in a patient with myasthenia gravis;Muscle & Nerve;2022-01-20